Engineering alternative butanol production platforms in heterologous bacteria.
. 2009. Engineering alternative butanol production platforms in heterologous bacteria. Metab Eng. 11(4-5):262-73. Google Scholar PubMed
Posts
Metabolic engineering of Escherichia coli for enhanced production of (R)- and (S)-3-hydroxybutyrate.
/0 Comments/in Publications /by syn-adminTseng H-C, Martin CH, Nielsen DR, Prather KLJones. 2009. Metabolic engineering of Escherichia coli for enhanced production of (R)- and (S)-3-hydroxybutyrate. Appl Environ Microbiol. 75(10):3137-45. Google Scholar PubMed
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy.
/0 Comments/in Publications /by syn-adminLu TK, Collins JJ. 2009. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc Natl Acad Sci U S A. 106(12):4629-34. Google Scholar PubMed
Engineering microbes with synthetic biology frameworks.
/0 Comments/in Publications /by syn-adminLeonard E, Nielsen D, Solomon K, Prather KJones. 2008. Engineering microbes with synthetic biology frameworks. Trends Biotechnol. 26(12):674-81. Google Scholar PubMed
De novo biosynthetic pathways: rational design of microbial chemical factories.
/0 Comments/in Publications /by syn-adminPrather KLJones, Martin CH. 2008. De novo biosynthetic pathways: rational design of microbial chemical factories. Curr Opin Biotechnol. 19(5):468-74. Google Scholar PubMed
Metabolic engineering of a novel propionate-independent pathway for the production of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) in recombinant Salmonella enterica serovar typhimurium.
/0 Comments/in Publications /by syn-adminAldor IS, Kim S-W, Prather KLJones, Keasling JD. 2002. Metabolic engineering of a novel propionate-independent pathway for the production of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) in recombinant Salmonella enterica serovar typhimurium. Appl Environ Microbiol. 68(8):3848-54. Google Scholar PubMed
